BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 17628041)

  • 1. Choice of non-inferiority (NI) margins does not protect against degradation of treatment effects on an average--an observational study of registered and published NI trials.
    Gladstone BP; Vach W
    PLoS One; 2014; 9(7):e103616. PubMed ID: 25080093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bayesian Approach for Assessing Non-inferiority in Three-arm Trials for Risk Ratio and Odds Ratio.
    Chowdhury S; Tiwari RC; Ghosh S
    Stat Biopharm Res; 2019; 11(1):34-43. PubMed ID: 31602287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NONPARAMETRIC TESTING FOR MULTIPLE SURVIVAL FUNCTIONS WITH NON-INFERIORITY MARGINS.
    Chang HW; McKeague IW
    Ann Stat; 2019 Feb; 47(1):205-232. PubMed ID: 31213730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of Noninferiority Tests to Examine the Food Insecurity-Obesity Relationship in Children.
    Swindle TM; Fitzgerald S; McKelvey L; Whiteside-Mansell L
    J Hunger Environ Nutr; 2018; 13(2):228-239. PubMed ID: 30906494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Non-Inferiority, Individually Randomized Trial of Intermittent Screening and Treatment versus Intermittent Preventive Treatment in the Control of Malaria in Pregnancy.
    Tagbor H; Cairns M; Bojang K; Coulibaly SO; Kayentao K; Williams J; Abubakar I; Akor F; Mohammed K; Bationo R; Dabira E; Soulama A; Djimdé M; Guirou E; Awine T; Quaye S; Njie F; Ordi J; Doumbo O; Hodgson A; Oduro A; Meshnick S; Taylor S; Magnussen P; ter Kuile F; Woukeu A; Milligan P; Chandramohan D; Greenwood B
    PLoS One; 2015; 10(8):e0132247. PubMed ID: 26258474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Methodological and statistical aspects of equivalence and non inferiority trials].
    Elie C; De Rycke Y; Jais JP; Marion-Gallois R; Landais P
    Rev Epidemiol Sante Publique; 2008 Aug; 56(4):267-77. PubMed ID: 18703296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A ratio test in active control non-inferiority trials with a time-to-event endpoint.
    Wang YC; Chen G; Chi GY
    J Biopharm Stat; 2006; 16(2):151-64. PubMed ID: 16584064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comments on 'active-control trials with binary data: a comparison of methods for testing superiority or non-inferiority using the odds ratio' by A. L. Siqueira, A. Whitehead and S. Todd, Statistics in Medicine 2008; 27:353-370.
    Martín Andrés A; Alvarez Hernández M
    Stat Med; 2008 Nov; 27(27):5799-800. PubMed ID: 18613285
    [No Abstract]   [Full Text] [Related]  

  • 9. Testing for treatment effect in the presence of regression toward the mean.
    George V; Johnson WD; Shahane A; Nick TG
    Biometrics; 1997 Mar; 53(1):49-59. PubMed ID: 9147603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methods for one-sided testing of the difference between proportions and sample size considerations related to non-inferiority clinical trials.
    Dann RS; Koch GG
    Pharm Stat; 2008; 7(2):130-41. PubMed ID: 17526060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Active-control trials with binary data: a comparison of methods for testing superiority or non-inferiority using the odds ratio.
    Siqueira AL; Whitehead A; Todd S
    Stat Med; 2008 Feb; 27(3):353-70. PubMed ID: 17628041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Issues on the selection of non-inferiority margin in clinical trials.
    Hou Y; Wu XY; Li K
    Chin Med J (Engl); 2009 Feb; 122(4):466-70. PubMed ID: 19302756
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.